{"product_id":"harvard-critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology-2025","title":"Harvard Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: oncologists, cancer researchers, immunologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTo celebrate the 40th anniversary, we have added a 5th Trainee-focused day to our course where the course participants will have the opportunity to present a scientific poster during a poster symposium, along with attend a roundtable discussion session on career guidance for  biomedical scientists and engineers.\u003c\/p\u003e\n\u003ch3\u003eLEARNING OBJECTIVES:\u003c\/h3\u003e\n\u003ch3\u003eUpon completion of our Critical Issues in Tumor Microenvironment course, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eIdentify pharmacological approaches to normalize the tumor microenvironment, including tumor-associated blood vessels, fibroblasts and the extracellular matrix\u003c\/p\u003e\n\u003cp\u003eEvaluate molecularly targeted agents approved or currently in clinical development in combination with immunotherapies for cancer treatment and incorporate them into practice.\u003c\/p\u003e\n\u003cp\u003eAssess relevant, state-of-the-art, or translational pre-clinical models of anti-cancer therapies for adult and pediatric malignancies.\u003c\/p\u003e\n\u003cp\u003eRecognize the steps and determinants of the metastatic process of cancer.\u003c\/p\u003e\n\u003cp\u003eIdentify emerging determinants of immunotherapy outcomes, including blood vessels, fibroblasts, extracellular matrix, neuronal-tumor interactions, circadian cycle, microbiome, and discuss potential approaches to harness them.\u003c\/p\u003e\n\u003cp\u003eCompare correlative studies of biomarkers and their response and resistance to immunotherapies in cancer patients.\u003c\/p\u003e\n\u003cp\u003eEvaluate state-of-the-art genetic and imaging techniques and their applications in pre-clinical and clinical studies.\u003c\/p\u003e\n\u003cp\u003eUnderstand the applications of AI in cancer care and research\u003c\/p\u003e\n\u003cp\u003eWho Should Attend This Course?\u003c\/p\u003e\n\u003cp\u003eThe course is directed at physicians and researchers.\u003c\/p\u003e\n\u003cp\u003eThe Harvard Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology 2025 course is best for oncologists, cancer researchers, immunologists, translational scientists, and advanced trainees who want cutting‑edge, multidisciplinary insights into tumor biology, angiogenesis, metastasis, immunology, and emerging therapies.\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eMedical oncologists and hematologists seeking deeper understanding of tumor biology to guide clinical practice.\u003c\/p\u003e\n\u003cp\u003eCancer researchers and translational scientists working on angiogenesis, metastasis, immunotherapy, and tumor microenvironment.\u003c\/p\u003e\n\u003cp\u003eImmunologists and molecular biologists studying immune regulation and cancer immunotherapy.\u003c\/p\u003e\n\u003cp\u003eRadiation and surgical oncologists interested in how microenvironmental factors influence treatment outcomes.\u003c\/p\u003e\n\u003cp\u003ePharmaceutical and biotech professionals developing anti‑cancer drugs, biologics, and cell therapies.\u003c\/p\u003e\n\u003cp\u003eGraduate students, postdocs, and fellows in oncology, immunology, or biomedical sciences preparing for academic or industry careers.\u003c\/p\u003e\n\u003cp\u003eWhat You’ll Learn\u003c\/p\u003e\n\u003cp\u003eTumor microenvironment fundamentals: angiogenesis, metastasis, immunology, metabolism, microbiome, and chronobiology.\u003c\/p\u003e\n\u003cp\u003eEmerging therapeutic strategies: adoptive cell therapies (CAR‑T, TCR), checkpoint inhibitors, and novel biologics.\u003c\/p\u003e\n\u003cp\u003eCancer neuroscience and fibroblast biology: how stromal and neural interactions drive tumor progression.\u003c\/p\u003e\n\u003cp\u003eIntegration of physical sciences and AI in oncology: innovative approaches to modeling and predicting tumor behavior.\u003c\/p\u003e\n\u003cp\u003eClinical translation: bridging laboratory discoveries with patient care to improve cancer treatment outcomes.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMonday, November 10, 2025\u003c\/p\u003e\n\u003cp\u003e9:00 A.M\u003c\/p\u003e\n\u003cp\u003eCheck-in\/Registration, Continental Breakfast\u003c\/p\u003e\n\u003cp\u003e10:00 A.M.\u003c\/p\u003e\n\u003cp\u003eOpening Remarks Rakesh K. Jain\u003c\/p\u003e\n\u003cp\u003e10:10 A.M.\u003c\/p\u003e\n\u003cp\u003eTumor Microenvironment I: Angiogenesis and Vascular Function Rakesh K. Jain\u003c\/p\u003e\n\u003cp\u003e11:20 A.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:35 A.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e11:50 A.M.\u003c\/p\u003e\n\u003cp\u003eTumor Microenvironment II: Vascular Normalization and Immunotherapy  Rakesh K. Jain\u003c\/p\u003e\n\u003cp\u003e1:10  P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:25 P.M.\u003c\/p\u003e\n\u003cp\u003eLunch Break – Boxed lunches provided\u003c\/p\u003e\n\u003cp\u003e2:25 P.M.\u003c\/p\u003e\n\u003cp\u003eTumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis Rakesh K. Jain\u003c\/p\u003e\n\u003cp\u003e3:45 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e4:00 P.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e4:30 P.M.\u003c\/p\u003e\n\u003cp\u003eCancer Immunology and Immunotherapy Overview Arlene Sharpe\u003c\/p\u003e\n\u003cp\u003e5:35 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e5:50 P.M.\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eTuesday, November 11, 2025\u003c\/p\u003e\n\u003cp\u003e9:00 A.M.\u003c\/p\u003e\n\u003cp\u003eContinental Breakfast\u003c\/p\u003e\n\u003cp\u003e10:00 A.M.\u003c\/p\u003e\n\u003cp\u003eCircadian Clock  and Metabolic Vulnerabilities of Cancer Chi Van Dang\u003c\/p\u003e\n\u003cp\u003e11:05 A.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:20 A.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e11:50 A.M.\u003c\/p\u003e\n\u003cp\u003eSkull Bone Marrow as a Site for Immuno-Surveillance of Healthy Brain and Brain Tumors Jonathan Kipnis\u003c\/p\u003e\n\u003cp\u003e12:55 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:10 P.M.\u003c\/p\u003e\n\u003cp\u003eLunch Break – on your own\u003c\/p\u003e\n\u003cp\u003e2:10 P.M.\u003c\/p\u003e\n\u003cp\u003eDeterminants of How Tumors Use Metabolism to Support Growth Matthew Vander Heiden\u003c\/p\u003e\n\u003cp\u003e3:15 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e3:30 P.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e4:00 P.M.\u003c\/p\u003e\n\u003cp\u003eUsing Cell Transfer to Remodel the Tumor Microenvrionment Carl June\u003c\/p\u003e\n\u003cp\u003e5:05 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e5:20 P.M.\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eWednesday, November 12, 2025\u003c\/p\u003e\n\u003cp\u003e9:00 A.M.\u003c\/p\u003e\n\u003cp\u003eContinental Breakfast\u003c\/p\u003e\n\u003cp\u003e10:00 A.M.\u003c\/p\u003e\n\u003cp\u003eAI in Basic and Clinical Oncology Eliezer Van Allen\u003c\/p\u003e\n\u003cp\u003e11:05 A.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:20 A.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e11:50 A.M.\u003c\/p\u003e\n\u003cp\u003eMicrobiota: a Key Orchestrator of Cancer Therapy Giorgio Trinchieri\u003c\/p\u003e\n\u003cp\u003e12:55 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:10  P.M.\u003c\/p\u003e\n\u003cp\u003eLunch Break – on your own\u003c\/p\u003e\n\u003cp\u003e2:10 P.M.\u003c\/p\u003e\n\u003cp\u003eIdentifying Immune Vulnerabilities in Solid Tumors Lisa Coussens\u003c\/p\u003e\n\u003cp\u003e3:15 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e3:30 P.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e4:00 P.M.\u003c\/p\u003e\n\u003cp\u003eRREBELLIOUS INTERFERENCE: Challenging old paradigms and discovering new strategies for targeting pediatric brain tumors Robert Wechsler-Reya\u003c\/p\u003e\n\u003cp\u003e5:05 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e5:20 P.M.\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eThursday, November 13, 2025\u003c\/p\u003e\n\u003cp\u003e9:00 A.M.\u003c\/p\u003e\n\u003cp\u003eContinental Breakfast\u003c\/p\u003e\n\u003cp\u003e10:00 A.M.\u003c\/p\u003e\n\u003cp\u003eDissecting the Ecosystem of Gliomas by Single-Cell and Spatial Genomics Mario Suva\u003c\/p\u003e\n\u003cp\u003e11:05 A.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:20 A.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e11:50 A.M.\u003c\/p\u003e\n\u003cp\u003eMechanisms of Malignant Progression Robert Weinberg\u003c\/p\u003e\n\u003cp\u003e12:55 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:10  P.M.\u003c\/p\u003e\n\u003cp\u003eLunch Break – on your own\u003c\/p\u003e\n\u003cp\u003e2:10 P.M.\u003c\/p\u003e\n\u003cp\u003eFibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer David Tuveson\u003c\/p\u003e\n\u003cp\u003e3:15 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e3:30 P.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e4:00 P.M.\u003c\/p\u003e\n\u003cp\u003eNeural Influences on Primary and Metastatic Brain Tumors Frank Winkler\u003c\/p\u003e\n\u003cp\u003e5:05 P.M.\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e5:20 P.M.\u003c\/p\u003e\n\u003cp\u003eSummary and closing remarks Rakesh K. Jain\u003c\/p\u003e\n\u003cp\u003eFriday , November 14th, 2025\u003c\/p\u003e\n\u003cp\u003e9:00  A.M.\u003c\/p\u003e\n\u003cp\u003ePoster set up\/ Continental Breakfast\u003c\/p\u003e\n\u003cp\u003e10:00 A.M.\u003c\/p\u003e\n\u003cp\u003eLessons from the Clinic: Novel Diagnostics and Therapeutic Outcomes George Sledge\u003c\/p\u003e\n\u003cp\u003e11:20 A.M.\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e11:50 A.M.\u003c\/p\u003e\n\u003cp\u003eEmerging strategies to improve CAR-T cell therapy for glioblastoma and other solid tumors Hideho Okada\u003c\/p\u003e\n\u003cp\u003e1:10 P.M.\u003c\/p\u003e\n\u003cp\u003eLunch Break – Boxed lunches will be provided\u003c\/p\u003e\n\u003cp\u003e2:10 P.M.\u003c\/p\u003e\n\u003cp\u003ePoster Session\u003c\/p\u003e\n\u003cp\u003e3:10 P.M.\u003c\/p\u003e\n\u003cp\u003ePoster Award Presentation\u003c\/p\u003e\n\u003cp\u003e3:30 P.M.\u003c\/p\u003e\n\u003cp\u003eCareer Round Table Discussion\u003c\/p\u003e\n\u003cp\u003eAcademia: Frank Winkler, MD, PhD |Eva Sevick-Muraca, PhD | Melody Swartz, PhD\u003c\/p\u003e\n\u003cp\u003eIndustry: George Sledge, MD | Zohreh Amoozgar, PhD\u003c\/p\u003e\n\u003cp\u003eLaw Firm: Carla Mouta-Bellum, PhD, JD\u003c\/p\u003e\n\u003cp\u003e5:00 P.M.\u003c\/p\u003e\n\u003cp\u003eNetworking Reception\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405800460484,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Critical-Issues-in-Tumor-Microenvironment-Angiogenesis-Metastasis-and-Immunology-2025.jpg?v=1784216355","url":"https:\/\/medicalcoursespro.com\/products\/harvard-critical-issues-in-tumor-microenvironment-angiogenesis-metastasis-and-immunology-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}